MapLight Therapeutics, Inc. financial statements
MapLight Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 161.15M | 10-K |
| Cash and equivalents | USD 46.73M | 10-Q |
| Total debt | USD 5.8M | EODHD |
MapLight Therapeutics, Inc. financials on 6ix · MapLight Therapeutics, Inc. on 6ix